Search Tag: Laurie Stelzer

2023 23 Aug

Mirati Therapeutics, Inc. ®  , a commercial stage biotechnology company announced that Laurie Stelzer, Chief Financial Officer, will depart the company on September 8, 2023, to pursue an external opportunity. Aaron Ondrey, senior vice president, financial planning and analysis (FP&A), Mirati Therapeutics, will assume the role of interim CFO. Ms. Stelzer...Read more